Prevalence and Management of Obesity in U.S. Adults With Type 1 Diabetes.
作者信息
Fang Michael, Jeon Yein, Echouffo-Tcheugui Justin B, Selvin Elizabeth
机构信息
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins School of Medicine, Baltimore, Maryland.
出版信息
Ann Intern Med. 2023 Mar;176(3):427-429. doi: 10.7326/M22-3078. Epub 2023 Feb 14.
Abstract
摘要
相似文献
1
Prevalence and Management of Obesity in U.S. Adults With Type 1 Diabetes.美国1型糖尿病成年患者肥胖的患病率及管理
Ann Intern Med. 2023 Mar;176(3):427-429. doi: 10.7326/M22-3078. Epub 2023 Feb 14.
2
Prevalence and Management of Obesity in U.S. Adults With Type 1 Diabetes.美国1型糖尿病成年患者中肥胖症的患病率及管理
Ann Intern Med. 2023 Sep;176(9):eL230227. doi: 10.7326/L23-0227.
3
Prevalence and Management of Obesity in U.S. Adults With Type 1 Diabetes.美国1型糖尿病成年患者肥胖症的患病率及管理
Ann Intern Med. 2023 Sep;176(9):eL230228. doi: 10.7326/L23-0228.
4
The Controversies in Obesity, Diabetes and Hypertension (CODHy) meeting: what is it all about?肥胖、糖尿病与高血压争议（CODHy）会议：究竟是关于什么的？
Diabetes Care. 2008 Feb;31 Suppl 2:S111-2. doi: 10.2337/dc08-s226.
5
Diabetes in Florida.佛罗里达州的糖尿病。
J Fla Med Assoc. 1998 Aug;85(2):20-1.
6
Geographic distribution of childhood diabetes and obesity relative to the supply of pediatric endocrinologists in the United States.美国儿童糖尿病和肥胖症的地理分布与儿科内分泌专家供应情况的关系。
J Pediatr. 2008 Mar;152(3):331-6. doi: 10.1016/j.jpeds.2007.08.037. Epub 2007 Nov 5.
7
Diabetes today. An update for patients and clinicians. Centers for Disease Control and Prevention.今日糖尿病：面向患者及临床医生的最新资讯。疾病控制与预防中心。
Adv Nurse Pract. 1999 Apr;7(4):64-6.
8
[Epidemiology of diabetes: frightening predictions].[糖尿病流行病学：可怕的预测]
Med Sci (Paris). 2013 Aug-Sep;29(8-9):711-4. doi: 10.1051/medsci/2013298008. Epub 2013 Sep 5.
9
Diabetes and baby boomers.糖尿病与婴儿潮一代。
Nev Rnformation. 1998 May;7(2):19-22.
10
Prevalence of Diagnosed Diabetes in Adults by Diabetes Type - United States, 2016.按糖尿病类型划分的美国成年人确诊糖尿病患病率，2016年
MMWR Morb Mortal Wkly Rep. 2018 Mar 30;67(12):359-361. doi: 10.15585/mmwr.mm6712a2.
引用本文的文献
1
Trends and Disparities in Technology Use and Glycemic Control in Type 1 Diabetes.1型糖尿病患者技术使用情况与血糖控制的趋势及差异
JAMA Netw Open. 2025 Aug 1;8(8):e2526353. doi: 10.1001/jamanetworkopen.2025.26353.
2
Cross-sectional association between the isocaloric replacement of carbohydrates with protein and fat in relation to fat compartments distribution and hepatic lipid content in recent-onset type 1 and type 2 diabetes.在新诊断的1型和2型糖尿病患者中，碳水化合物等量替换为蛋白质和脂肪与脂肪分布及肝脏脂质含量之间的横断面关联。
Nutr J. 2025 May 10;24(1):74. doi: 10.1186/s12937-025-01145-1.
3
Type 1 diabetes presenting in adults: Trends, diagnostic challenges and unique features.成人1型糖尿病：趋势、诊断挑战及独特特征
Diabetes Obes Metab. 2025 Apr 15. doi: 10.1111/dom.16402.
4
From fat to filter: the effect of adipose tissue-derived signals on kidney function.从脂肪到滤过器：脂肪组织衍生信号对肾功能的影响。
Nat Rev Nephrol. 2025 Apr 2. doi: 10.1038/s41581-025-00950-5.
5
Trends in obesity and glucagon-like peptide-1 receptor agonist prescriptions in type 1 diabetes in the United States.美国1型糖尿病患者肥胖及胰高血糖素样肽-1受体激动剂处方的趋势
Diabetes Obes Metab. 2025 Jun;27(6):2967-2976. doi: 10.1111/dom.16300. Epub 2025 Mar 3.
6
Glucagon-like peptide-1 receptor agonists and type 1 diabetes: a potential game changer?胰高血糖素样肽-1受体激动剂与1型糖尿病：会是一个潜在的游戏规则改变者吗？
Front Endocrinol (Lausanne). 2025 Jan 21;15:1520313. doi: 10.3389/fendo.2024.1520313. eCollection 2024.
7
Managing obesity in adults with type 1 diabetes.管理1型糖尿病成年患者的肥胖问题。
Diabetes Res Clin Pract. 2025 Feb;220:111983. doi: 10.1016/j.diabres.2024.111983. Epub 2024 Dec 31.
8
Effectiveness and Safety of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes.胰高血糖素样肽-1受体激动剂在1型糖尿病患者中的有效性和安全性
J Clin Med. 2024 Oct 30;13(21):6532. doi: 10.3390/jcm13216532.
9
Body weight variability as a predictor of cardiovascular outcomes in type 1 diabetes: A nationwide cohort study.1型糖尿病患者体重变异性作为心血管结局预测因素的全国性队列研究
Diabetes Obes Metab. 2025 Feb;27(2):490-500. doi: 10.1111/dom.16038. Epub 2024 Oct 28.
10
Differential Efficacy of Weight Loss Interventions in Patients with Versus Without Diabetes.有糖尿病与无糖尿病患者减肥干预措施的疗效差异
Diabetes Ther. 2024 Nov;15(11):2279-2291. doi: 10.1007/s13300-024-01646-y. Epub 2024 Sep 14.
本文引用的文献
1
Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts.1 型糖尿病的死亡率趋势：六项基于人群的多国队列分析。
Diabetologia. 2022 Jun;65(6):964-972. doi: 10.1007/s00125-022-05659-9. Epub 2022 Mar 22.
2
Obesity and Chronic Kidney Disease in US Adults With Type 1 and Type 2 Diabetes Mellitus.美国 1 型和 2 型糖尿病成人的肥胖与慢性肾脏病。
J Clin Endocrinol Metab. 2022 Apr 19;107(5):1247-1256. doi: 10.1210/clinem/dgab927.
3
Obesity in people living with type 1 diabetes.1 型糖尿病患者的肥胖问题。
Lancet Diabetes Endocrinol. 2021 Nov;9(11):776-785. doi: 10.1016/S2213-8587(21)00246-1. Epub 2021 Sep 30.
4
The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).《成人 1 型糖尿病管理：美国糖尿病协会 (ADA) 与欧洲糖尿病研究协会 (EASD) 的共识报告》
Diabetes Care. 2021 Nov;44(11):2589-2625. doi: 10.2337/dci21-0043. Epub 2021 Sep 30.
5
Prevalence of Diagnosed Diabetes in Adults by Diabetes Type - United States, 2016.按糖尿病类型划分的美国成年人确诊糖尿病患病率，2016年
MMWR Morb Mortal Wkly Rep. 2018 Mar 30;67(12):359-361. doi: 10.15585/mmwr.mm6712a2.
Zotero 插件